DK158980C - Analogifremgangsmaade til fremstilling af 2,5-bis-(2,2,2-trifluorethoxy)-n-(2-piperidylmethyl)benzamid eller et farmaceutisk acceptabelt syreadditionssalt deraf - Google Patents
Analogifremgangsmaade til fremstilling af 2,5-bis-(2,2,2-trifluorethoxy)-n-(2-piperidylmethyl)benzamid eller et farmaceutisk acceptabelt syreadditionssalt derafInfo
- Publication number
- DK158980C DK158980C DK119675A DK119675A DK158980C DK 158980 C DK158980 C DK 158980C DK 119675 A DK119675 A DK 119675A DK 119675 A DK119675 A DK 119675A DK 158980 C DK158980 C DK 158980C
- Authority
- DK
- Denmark
- Prior art keywords
- trifluorethoxy
- piperidylmethyl
- benzamide
- analogue
- bis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45709974 | 1974-04-01 | ||
US457099A US3900481A (en) | 1974-04-01 | 1974-04-01 | Derivatives of pyrrolidine and piperidine |
Publications (3)
Publication Number | Publication Date |
---|---|
DK119675A DK119675A (xx) | 1975-10-02 |
DK158980B DK158980B (da) | 1990-08-13 |
DK158980C true DK158980C (da) | 1991-01-07 |
Family
ID=23815433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK119675A DK158980C (da) | 1974-04-01 | 1975-03-21 | Analogifremgangsmaade til fremstilling af 2,5-bis-(2,2,2-trifluorethoxy)-n-(2-piperidylmethyl)benzamid eller et farmaceutisk acceptabelt syreadditionssalt deraf |
Country Status (22)
Country | Link |
---|---|
US (1) | US3900481A (xx) |
JP (2) | JPS5827268B2 (xx) |
AR (1) | AR210990A1 (xx) |
BE (1) | BE827354A (xx) |
CA (1) | CA1054602A (xx) |
CH (1) | CH618425A5 (xx) |
CS (1) | CS209846B2 (xx) |
DE (1) | DE2513916C2 (xx) |
DK (1) | DK158980C (xx) |
ES (1) | ES435870A1 (xx) |
FR (1) | FR2265366B1 (xx) |
GB (1) | GB1508015A (xx) |
HU (1) | HU169762B (xx) |
IE (1) | IE41224B1 (xx) |
IL (1) | IL46967A (xx) |
NL (1) | NL186633C (xx) |
NO (1) | NO144262C (xx) |
OA (1) | OA04912A (xx) |
PL (1) | PL95576B1 (xx) |
SE (1) | SE391336B (xx) |
SU (1) | SU668599A3 (xx) |
ZA (1) | ZA751040B (xx) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1520584A (en) * | 1975-04-02 | 1978-08-09 | Yamanouchi Pharma Co Ltd | 2 - alkoxy - 5 substituted benzamide derivatives and their use in pharmaceutical compositions |
US4197243A (en) * | 1975-04-02 | 1980-04-08 | Yamanouchi Pharmaceutical Co., Ltd. | N-1-Benzyl-3-pyrrolidinyl-4-dimethylamino benzamide derivatives |
FI763021A (xx) * | 1975-11-03 | 1977-05-04 | Thomae Gmbh Dr K | |
US4097481A (en) * | 1976-11-08 | 1978-06-27 | Riker Laboratories, Inc. | Tertiary amide derivatives of pyrrolidine and piperidine |
US4071524A (en) * | 1976-11-08 | 1978-01-31 | Riker Laboratories, Inc. | Derivatives of urea |
JPS55143967A (en) * | 1979-03-19 | 1980-11-10 | Riker Laboratories Inc | Manufacture of 2*55bis*2*2*22trifluoroethoxy** nn*22piperidylmethyl*benzamide |
GB2097000B (en) * | 1979-03-19 | 1983-11-30 | Riker Laboratories Inc | Process for the preparation of 1,4-bis(2,2,2-trifluoroethoxy) benzene |
US4617396A (en) * | 1979-03-19 | 1986-10-14 | Riker Laboratories, Inc. | Process for the preparation of derivatives of piperidine |
US4642384A (en) * | 1979-03-19 | 1987-02-10 | Riker Laboratories, Inc. | Process for the preparation of derivatives of pyrrolidine and piperidine |
US4684733A (en) * | 1979-03-19 | 1987-08-04 | Riker Laboratories, Inc. | Process for the preparation of intermediates of derivatives of pyrrolidine and piperidine |
US4339587A (en) * | 1981-06-08 | 1982-07-13 | Riker Laboratories, Inc. | 5-Benzyloxy or 5-hydroxy-2-(2,2,2-trifluoroethoxy)-N-(2-pyridylmethyl)benzamide |
US4452983A (en) * | 1981-06-08 | 1984-06-05 | Riker Laboratories, Inc. | Phenolic derivative |
US4390716A (en) * | 1981-06-08 | 1983-06-28 | Riker Laboratories, Inc. | Phenolic derivative |
JPS5970666A (ja) * | 1982-10-15 | 1984-04-21 | Kyowa Hakko Kogyo Co Ltd | 1,4−ジヒドロピリジン誘導体 |
US4555573A (en) * | 1983-11-15 | 1985-11-26 | Riker Laboratories, Inc. | Certain 6-benzamidomethyl-2(1H)-pyridone derivatives |
US4497954A (en) * | 1983-11-15 | 1985-02-05 | Riker Laboratories, Inc. | Cyclopentanone derivatives |
US4656285A (en) * | 1983-11-15 | 1987-04-07 | Riker Laboratories, Inc. | Compound 2-acetamidomethyl-6-methoxy-pyridine |
US4599434A (en) * | 1983-11-15 | 1986-07-08 | Riker Laboratories, Inc. | Cyclopentanone derivatives |
US4496734A (en) * | 1983-11-15 | 1985-01-29 | Riker Laboratories, Inc. | Metabolite |
EP0242847B1 (en) * | 1986-04-25 | 1993-06-02 | Abbott Laboratories | Tracers for use in flecainide fluorescence polarization immunoassay |
NZ219913A (en) * | 1986-04-25 | 1990-08-28 | Riker Laboratories Inc | Various flecainide derivatives and antibodies raised thereto |
US5336622A (en) * | 1986-04-25 | 1994-08-09 | Abbott Laboratories | Tracers for use in flecainide fluorescence polarization immunoassay |
US4952574A (en) * | 1988-09-26 | 1990-08-28 | Riker Laboratories, Inc. | Antiarrhythmic substituted N-(2-piperidylmethyl)benzamides |
US4938966A (en) * | 1988-11-30 | 1990-07-03 | Riker Laboratories, Inc. | Controlled release flecainide acetate formulation |
US5254569A (en) * | 1991-01-14 | 1993-10-19 | The Du Pont Merck Pharmaceutical Company | (Amidomethyl)nitrogen heterocyclic analgesics |
IL121288A (en) * | 1997-07-11 | 2000-10-31 | Finetech Ltd | Process and a novel intermediate for the preparation of flecainide |
ITMI20011772A1 (it) * | 2001-08-10 | 2003-02-10 | A M S A Anonima Materie Sint E | Processo per la preparazione della 2,5-bis-(2,2,2-trifluoroetossi)-n-(2-piperidilmetil)-benzamide(flecainide) |
EP1500651A1 (en) * | 2003-07-25 | 2005-01-26 | Bayer CropScience S.A. | N-[2-(2-Pyridinyl)ethyl]benzamide compounds and their use as fungicides |
US7196197B2 (en) * | 2003-09-17 | 2007-03-27 | Apotex Pharmachem Inc. | Process for the preparation of Flecainide, its pharmaceutically acceptable salts and important intermediates thereof |
EP1918280A1 (en) * | 2006-11-06 | 2008-05-07 | "Joint Stock Company Grindeks" | Process for the preparation of 2,5-bis-(2,2,2-trifluoroethoxy)-N-(2-piperidylmethyl)-benzamide and salts thereof |
EP2425858A3 (en) | 2006-11-20 | 2012-03-28 | President and Fellows of Harvard College | Compositions for treating pain and pruritus |
JP4946482B2 (ja) | 2007-02-08 | 2012-06-06 | 船井電機株式会社 | 緩衝用梱包材及びtv受像機の緩衝用梱包材 |
WO2011006073A1 (en) | 2009-07-10 | 2011-01-13 | President And Fellows Of Harvard College | Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
CN108348774A (zh) | 2015-08-03 | 2018-07-31 | 哈佛大学校长及研究员协会 | 带电离子通道阻断剂及其应用 |
MX2021010869A (es) | 2019-03-11 | 2022-01-19 | Nocion Therapeutics Inc | Bloqueadores de canales iónicos sustituidos por éster y métodos para su uso. |
JP2022527438A (ja) | 2019-03-11 | 2022-06-02 | ノシオン セラピューティクス,インコーポレイテッド | 荷電したイオンチャンネル遮断薬および使用方法 |
US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
CN113811305A (zh) | 2019-03-11 | 2021-12-17 | 诺西恩医疗公司 | 带电的离子通道阻滞剂及其使用方法 |
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
JP7513713B2 (ja) | 2019-11-06 | 2024-07-09 | ノシオン セラピューティクス,インコーポレイテッド | 荷電したイオンチャンネル遮断薬および使用方法 |
EP4054559A4 (en) | 2019-11-06 | 2023-11-29 | Nocion Therapeutics, Inc. | CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE |
KR20230022830A (ko) | 2020-03-11 | 2023-02-16 | 녹시온 테라퓨틱스 인코포레이티드 | 하전된 이온 채널 차단제 및 사용 방법 |
WO2024132080A1 (en) | 2022-12-22 | 2024-06-27 | Colonis Pharma Ltd | Liquid pharmaceutical composition containing flecainide and process for the preparaton thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR6209M (xx) * | 1967-04-03 | 1968-07-29 | ||
US3655728A (en) * | 1970-07-22 | 1972-04-11 | Riker Laboratories Inc | N-(2 - dialkylaminoalkylene)-esters of fluoroalkoxy-substituted aryl carboxylic acid and salts thereof |
US3719687A (en) * | 1970-07-22 | 1973-03-06 | Riker Laboratories Inc | N-(2-dialkylaminoalkylene)amides of 1,1-dihydroperfluoroalkoxy-substituted aryl acids and salts thereof |
-
1974
- 1974-04-01 US US457099A patent/US3900481A/en not_active Expired - Lifetime
-
1975
- 1975-02-19 ZA ZA00751040A patent/ZA751040B/xx unknown
- 1975-03-21 SE SE7503262A patent/SE391336B/xx active Protection Beyond IP Right Term
- 1975-03-21 ES ES435870A patent/ES435870A1/es not_active Expired
- 1975-03-21 NO NO750976A patent/NO144262C/no unknown
- 1975-03-21 DK DK119675A patent/DK158980C/da active
- 1975-03-21 NL NLAANVRAGE7503389,A patent/NL186633C/xx not_active IP Right Cessation
- 1975-03-27 CA CA223241A patent/CA1054602A/en not_active Expired
- 1975-03-27 OA OA55453A patent/OA04912A/xx unknown
- 1975-03-27 IE IE700/75A patent/IE41224B1/xx unknown
- 1975-03-27 DE DE2513916A patent/DE2513916C2/de not_active Expired
- 1975-03-27 GB GB13027/75A patent/GB1508015A/en not_active Expired
- 1975-03-27 CH CH403075A patent/CH618425A5/de not_active IP Right Cessation
- 1975-03-28 FR FR7509953A patent/FR2265366B1/fr not_active Expired
- 1975-03-28 BE BE154920A patent/BE827354A/xx active Protection Beyond IP Right Term
- 1975-03-28 HU HURI561A patent/HU169762B/hu unknown
- 1975-03-28 CS CS752168A patent/CS209846B2/cs unknown
- 1975-03-31 IL IL46967A patent/IL46967A/xx unknown
- 1975-03-31 JP JP50039035A patent/JPS5827268B2/ja not_active Expired
- 1975-03-31 AR AR258179A patent/AR210990A1/es active
- 1975-03-31 SU SU752117802A patent/SU668599A3/ru active
- 1975-04-01 PL PL1975179258A patent/PL95576B1/pl unknown
-
1982
- 1982-08-27 JP JP57149020A patent/JPS5858347B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NO750976L (xx) | 1975-10-02 |
US3900481A (en) | 1975-08-19 |
DK119675A (xx) | 1975-10-02 |
NL186633B (nl) | 1990-08-16 |
JPS5827268B2 (ja) | 1983-06-08 |
AU7957875A (en) | 1976-09-30 |
FR2265366B1 (xx) | 1980-01-11 |
SE7503262L (xx) | 1975-10-02 |
SE391336B (sv) | 1977-02-14 |
NL7503389A (nl) | 1975-10-03 |
CS209846B2 (en) | 1981-12-31 |
JPS50137975A (xx) | 1975-11-01 |
CH618425A5 (xx) | 1980-07-31 |
OA04912A (fr) | 1980-10-31 |
IL46967A (en) | 1978-09-29 |
IL46967A0 (en) | 1975-05-22 |
DE2513916C2 (de) | 1982-12-23 |
GB1508015A (en) | 1978-04-19 |
ZA751040B (en) | 1976-01-28 |
BE827354A (fr) | 1975-09-29 |
HU169762B (xx) | 1977-02-28 |
CA1054602A (en) | 1979-05-15 |
NO144262B (no) | 1981-04-21 |
JPS5865268A (ja) | 1983-04-18 |
NO144262C (no) | 1981-07-29 |
NL186633C (nl) | 1991-01-16 |
IE41224B1 (en) | 1979-11-21 |
SU668599A3 (ru) | 1979-06-15 |
DK158980B (da) | 1990-08-13 |
JPS5858347B2 (ja) | 1983-12-24 |
FR2265366A1 (xx) | 1975-10-24 |
DE2513916A1 (de) | 1975-10-09 |
AR210990A1 (es) | 1977-10-14 |
PL95576B1 (pl) | 1977-10-31 |
IE41224L (en) | 1975-10-01 |
ES435870A1 (es) | 1976-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK158980C (da) | Analogifremgangsmaade til fremstilling af 2,5-bis-(2,2,2-trifluorethoxy)-n-(2-piperidylmethyl)benzamid eller et farmaceutisk acceptabelt syreadditionssalt deraf | |
DK151623C (da) | Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
DK149597C (da) | Analogifremgangsmaade til fremstilling af calcitoninanaloge hentriaconpeptidderivater eller farmaceutisk acceptable syreadditionssalte eller komplekser deraf | |
DK151331C (da) | Analogifremgangsmaade til fremstilling af 5-pyridinyl-2(1h)-pyridinon-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
DK148904C (da) | Analogifremgangsmaade til fremstilling af analgetisk virksomme enkephalin-analoge pentapeptidamider eller farmaceutisk acceptable, ikke-toxiske syreadditionssalte deraf | |
DK160045C (da) | Analogifremgangsmaade til fremstilling af 4-oxo-4h-pyridooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere ammoniumsalte deraf | |
DK149230C (da) | Analogifremgangsmaade til fremstilling af 5-benzoyl-6-hydroxy-indan-1-carboxylsyrederivater eller farmaceutisk acceptable salte deraf | |
DK154950C (da) | Analogifremgangsmaade til fremstilling af 1-(benzazolylalkyl)-piperidinderivater eller de farmaceutisk acceptable syreadditionssalte deraf | |
DK149231C (da) | Analogifremgangsmaade til fremstilling af enkephalin-analoge tetrapeptidamider eller syreadditionssalte deraf | |
DK149625C (da) | Analogifremgangsmaade til fremstilling af n-substituerede (8-halogen- eller -trifluormethyl-4-quinolylamino)-benzamider eller et farmaceutiskacceptabelt syreadditionssalt deraf | |
DK149946C (da) | Analogifremgangsmaade til fremstilling af piperidin-derivater af 1,2- eller 1,3-(di-o-n-alkyl)propandiol eller farmaceutisk acceptable syreadditionssalte deraf | |
DK149841C (da) | Analogifremgangsmaade til fremstilling af alfa-fluor-methyl-alfa-aminoalkansyrer eller farmaceutisk acceptable syreadditionssalte deraf | |
DK155672C (da) | Analogifremgangsmaade til fremstilling af aminosyrederivater eller fysiologisk acceptable salte eller optisk aktive isomerer deraf | |
DK143278C (da) | Analogifremgangsmaade til fremstilling af n-(r-tetrahydrofurfuryl)-noroxymorphon eller syreadditionssalte deraf | |
DK152208C (da) | Analogifremgangsmaade til fremstilling af 2-phenylamino-phenyleddikesyreamider eller farmaceutisk acceptable salte deraf | |
DK159435C (da) | Analogifremgangsmaade til fremstilling af 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoesyrederivater eller et farmaceutisk acceptabelt syreadditionssalt deraf | |
DK498975A (da) | N2-naphthalensulfonyl-l-arginin-derivater og farmaceutisk acceptable syreadditionssalte deraf samt deres anvendelse og fremgangsmade til deres fremstilling | |
DK384975A (da) | Anthelmintisk virksomme 2-carbalkoxyaminobenzimidazolyl-5(6)-sulfonsyrephenylestere samt fremgangsmade til deres fremstilling | |
DK153759C (da) | Analogifremgangsmaade til fremstilling af prostansyrederivater | |
DK152211C (da) | Analogifremgangsmaade til fremstilling af n-phenyl-n-(4-piperidinyl)-amider eller farmaceutisk acceptable syreadditionssalte deraf. | |
DK157021C (da) | Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf | |
DK146851C (da) | Analogifremgangsmaade til fremstilling af benzylaminer eller deres syreadditionssalte af en- eller flerbasiske, fysiologisk acceptable syrer | |
DK142987C (da) | Analogifremgangsmaade til fremstilling af 4-(7-brom-5-methoxy-2-benzofuranyl)-piperidin eller farmaceutisk acceptable syreadditionssalte deraf | |
DK147577C (da) | Analogifremgangsmaade til fremstilling af 2-phenyl-bicyclooctan- eller -octenaminer eller farmaceutisk acceptable syreadditionssalte deraf | |
DK143197C (da) | Analogifremgangsmaade til fremstilling af 5,7-dihydroxy-tetrahydroisoquinoliner eller farmaceutisk acceptable syreadditionssalte deraf |